UK launches panel to tackle research misconduct

BMJ 2006; 332 doi: 10.1136/bmj.332.7546.871-a (Published 13 April 2006)
Cite this as: BMJ 2006;332:871.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Andrew Cole
  1. London

    A new independent body to tackle biomedical research misconduct in the United Kingdom was launched this week—but its powers will be limited to providing advice and promoting good practice.

    The UK Panel for Health and Biomedical Research Integrity has been initially set up as a three year project, and its first priority will be to develop a code of practice applicable to universities, the NHS, and industry.

    The panel will also support whistleblowers reporting cases of alleged research fraud in addition to offering training, seminars, and advice on …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL